Levetiracetam Jubilant (Levetiracetam)

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A in the brain. This binding modulates the release of neurotransmitters, stabilising neuronal firing and reducing excessive electrical activity that can trigger seizures.

The appropriate dose of levetiracetam is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Starting doses and titration schedules vary, and the prescriber will tailor the regimen to achieve optimal seizure control while minimising side effects.

Safety data for levetiracetam in pregnancy are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus. Breastfeeding mothers should discuss potential exposure with their healthcare provider, as levetiracetam can be excreted in breast milk.

To request Levetiracetam Jubilant, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the enquiry, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details and any required import documentation.

Levetiracetam offers a favourable safety profile and does not require routine therapeutic drug monitoring, unlike some older antiepileptics such as phenytoin or carbamazepine. It has fewer drug‑enzyme interactions, making it a convenient option for patients on multiple medications, though individual response and tolerability can vary.

Store Levetiracetam Jubilant at room temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, direct sunlight and excessive heat to maintain potency throughout its shelf life.

Levetiracetam Jubilant is taken orally. The tablets should be swallowed whole with water and may be taken with or without food, according to the prescriber’s instructions.

Serious adverse reactions, although rare, include severe allergic responses such as Stevens‑Johnson syndrome, life‑threatening skin eruptions, and psychiatric effects like suicidal thoughts or severe depression. Prompt medical attention is required if any of these symptoms develop.

Levetiracetam is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications that may significantly alter its efficacy.